FDA Commissioner Plans Trip to India to Discuss Regulatory Cooperation
Food and Drug Administration Commissioner Margaret Hamburg will travel to India Feb. 10-18 for meetings intended to strengthen cooperation between FDA and Indian regulators. During the trip, which will include visits to Delhi, Cochin, and Mumbai, Commissioner Hamburg will meet with Indian policy and government leaders involved in the regulation of medical and food products exported to the U.S., said FDA in its press release. Currently, India is the second largest exporter of finished drug products and the eighth largest exporter of food products to the United States, it said.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
“The FDA’s ongoing engagement with our regulatory counterparts in India is critical to our ability to effectively promote the health and safety of American and Indian consumers,” said Hamburg. “I look forward to enhancing our existing relationship and identifying additional opportunities for collaboration.”